Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,092)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Pharvaris N.V. | PHVS | $30.66 | $2.15B | — | |
| Axogen, Inc. | AXGN | $36.48 | $2.14B | — | |
| Immunome, Inc. | IMNM | $18.00 | $2.12B | — | |
| Trulieve Cannabis Corp. | TRLV | $11.00 | $2.12B | — | |
| Vericel Corporation | VCEL | $40.94 | $2.10B | 87.1 | — |
| GeneDx Holdings Corp. | WGS | $68.94 | $2.06B | — | |
| Inspire Medical Systems, Inc. | INSP | $71.07 | $2.05B | 15.7 | — |
| BioCryst Pharmaceuticals, Inc. | BCRX | $7.75 | $2.03B | — | |
| Zymeworks Inc. | ZYME | $28.12 | $2.02B | — | |
| Surgery Partners, Inc. | SGRY | $15.40 | $2.02B | — | |
| Lakefront Biotherapeutics NV | LKFT | $30.58 | $2.00B | 2.9 | — |
| Xeris Biopharma Holdings, Inc. | XERS | $10.79 | $1.97B | — | |
| Sarepta Therapeutics, Inc. | SRPT | $18.56 | $1.96B | — | |
| Recursion Pharmaceuticals, Inc. | RXRX | $3.64 | $1.95B | — | |
| Butterfly Network, Inc. | BFLY | $7.10 | $1.95B | — | |
| LeMaitre Vascular, Inc. | LMAT | $83.67 | $1.91B | 29.4 | 1.20% |
| Septerna, Inc. | SEPN | $40.76 | $1.90B | — | |
| Xencor, Inc. | XNCR | $25.16 | $1.87B | — | |
| Mineralys Therapeutics, Inc. | MLYS | $21.10 | $1.87B | — | |
| Establishment Labs Holdings Inc. | ESTA | $62.28 | $1.86B | — | |
| Astrana Health, Inc. | ASTH | $37.35 | $1.85B | 45.0 | — |
| Alvotech | ALVO | $5.13 | $1.83B | — | |
| Zenas BioPharma, Inc. | ZBIO | $28.08 | $1.83B | — | |
| ADARx Pharmaceuticals, Inc. | ADRX | $17.13 | $1.83B | — | |
| Palvella Therapeutics, Inc. | PVLA | $126.58 | $1.82B | — | |
| Trevi Therapeutics, Inc. | TRVI | $12.77 | $1.82B | — | |
| Novavax, Inc. | NVAX | $11.01 | $1.82B | — | |
| NovoCure Limited | NVCR | $15.59 | $1.82B | — | |
| DENTSPLY SIRONA Inc. | XRAY | $9.08 | $1.81B | — | |
| Maze Therapeutics, Inc. | MAZE | $32.58 | $1.81B | — | |
| Vir Biotechnology, Inc. | VIR | $10.57 | $1.79B | — | |
| Schrödinger, Inc. | SDGR | $23.90 | $1.79B | — | |
| Alignment Healthcare, Inc. | ALHC | $8.44 | $1.75B | 44.4 | — |
| Braveheart Bio, Inc. | BRVE | $21.04 | $1.74B | — | |
| UroGen Pharma Ltd. | URGN | $35.48 | $1.73B | — | |
| Absci Corporation | ABSI | $10.04 | $1.72B | — | |
| Biohaven Ltd. | BHVN | $11.75 | $1.71B | — | |
| Nuvation Bio Inc. | NUVB | $4.85 | $1.70B | — | |
| Ardent Health, Inc. | ARDT | $12.06 | $1.70B | 22.3 | — |
| Personalis, Inc. | PSNL | $15.90 | $1.70B | — | |
| Generate Biomedicines, Inc. | GENB | $13.11 | $1.68B | — | |
| Alphatec Holdings, Inc. | ATEC | $10.86 | $1.68B | — | |
| Kailera Therapeutics, Inc. | KLRA | $12.92 | $1.67B | — | |
| Mesoblast Limited | MESO | $12.83 | $1.67B | — | |
| AMN Healthcare Services, Inc. | AMN | $43.01 | $1.67B | 16.1 | — |
| ANI Pharmaceuticals, Inc. | ANIP | $72.24 | $1.66B | 15.6 | — |
| Stoke Therapeutics, Inc. | STOK | $25.68 | $1.66B | — | |
| Omnicell, Inc. | OMCL | $36.34 | $1.65B | 43.3 | — |
| Immunocore Holdings plc | IMCR | $32.09 | $1.65B | — | |
| Intellia Therapeutics, Inc. | NTLA | $11.65 | $1.63B | — |
Pharvaris N.V.
Healthcare / Biotechnology
- Market Cap
- $2.15B
- P/E
- unprofitable
Axogen, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.14B
- P/E
- unprofitable
Immunome, Inc.
Healthcare / Biotechnology
- Market Cap
- $2.12B
- P/E
- unprofitable
Trulieve Cannabis Corp.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.12B
- P/E
- unprofitable
Vericel Corporation
Healthcare / Biotechnology
- Market Cap
- $2.10B
- P/E
- 87.1
GeneDx Holdings Corp.
Healthcare / Diagnostics & Research
- Market Cap
- $2.06B
- P/E
- unprofitable
Inspire Medical Systems, Inc.
Healthcare / Medical Devices
- Market Cap
- $2.05B
- P/E
- 15.7
BioCryst Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $2.03B
- P/E
- unprofitable
Zymeworks Inc.
Healthcare / Biotechnology
- Market Cap
- $2.02B
- P/E
- unprofitable
Surgery Partners, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $2.02B
- P/E
- unprofitable
Lakefront Biotherapeutics NV
Healthcare / Biotechnology
- Market Cap
- $2.00B
- P/E
- 2.9
Xeris Biopharma Holdings, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.97B
- P/E
- unprofitable
Sarepta Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.96B
- P/E
- unprofitable
Recursion Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.95B
- P/E
- unprofitable
Butterfly Network, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.95B
- P/E
- unprofitable
LeMaitre Vascular, Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.91B
- P/E
- 29.4
- Dividend Yield
- 1.20%
Septerna, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.90B
- P/E
- unprofitable
Xencor, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.87B
- P/E
- unprofitable
Mineralys Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.87B
- P/E
- unprofitable
Establishment Labs Holdings Inc.
Healthcare / Medical Devices
- Market Cap
- $1.86B
- P/E
- unprofitable
Astrana Health, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.85B
- P/E
- 45.0
Alvotech
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.83B
- P/E
- unprofitable
Zenas BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.83B
- P/E
- unprofitable
ADARx Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.83B
- P/E
- unprofitable
Palvella Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.82B
- P/E
- unprofitable
Trevi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.82B
- P/E
- unprofitable
Novavax, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.82B
- P/E
- unprofitable
NovoCure Limited
Healthcare / Medical Devices
- Market Cap
- $1.82B
- P/E
- unprofitable
DENTSPLY SIRONA Inc.
Healthcare / Medical Instruments & Supplies
- Market Cap
- $1.81B
- P/E
- unprofitable
Maze Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.81B
- P/E
- unprofitable
Vir Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.79B
- P/E
- unprofitable
Schrödinger, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.79B
- P/E
- unprofitable
Alignment Healthcare, Inc.
Healthcare / Healthcare Plans
- Market Cap
- $1.75B
- P/E
- 44.4
Braveheart Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.74B
- P/E
- unprofitable
UroGen Pharma Ltd.
Healthcare / Biotechnology
- Market Cap
- $1.73B
- P/E
- unprofitable
Absci Corporation
Healthcare / Biotechnology
- Market Cap
- $1.72B
- P/E
- unprofitable
Biohaven Ltd.
Healthcare / Biotechnology
- Market Cap
- $1.71B
- P/E
- unprofitable
Nuvation Bio Inc.
Healthcare / Biotechnology
- Market Cap
- $1.70B
- P/E
- unprofitable
Ardent Health, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.70B
- P/E
- 22.3
Personalis, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $1.70B
- P/E
- unprofitable
Generate Biomedicines, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.68B
- P/E
- unprofitable
Alphatec Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $1.68B
- P/E
- unprofitable
Kailera Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.67B
- P/E
- unprofitable
Mesoblast Limited
Healthcare / Biotechnology
- Market Cap
- $1.67B
- P/E
- unprofitable
AMN Healthcare Services, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $1.67B
- P/E
- 16.1
ANI Pharmaceuticals, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $1.66B
- P/E
- 15.6
Stoke Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.66B
- P/E
- unprofitable
Omnicell, Inc.
Healthcare / Health Information Services
- Market Cap
- $1.65B
- P/E
- 43.3
Immunocore Holdings plc
Healthcare / Biotechnology
- Market Cap
- $1.65B
- P/E
- unprofitable
Intellia Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $1.63B
- P/E
- unprofitable
Showing 251–300 of 1,092 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.